Skip to content
10-K

Annual Report

Rain Oncology Inc.

0001558370-23-003331

← back to feed
Filed
Mar 9, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Feb 28, 2023 36.36M sh
Shares Diluted FY 2022 · Dec 31, 2022 27.99M sh
Shares Diluted FY 2022 · Dec 31, 2021 19.41M sh
Capex FY 2022 · Dec 31, 2022 $8K
Capex FY 2022 · Dec 31, 2021 $128K
Operating Cash Flow FY 2022 · Dec 31, 2022 −$63.2M
Operating Cash Flow FY 2022 · Dec 31, 2021 −$37.46M
Short Term Investments FY 2022 · Dec 31, 2022 $68.5M
Short Term Investments FY 2022 · Dec 31, 2021 $115.44M
Cash And Equivalents FY 2022 · Dec 31, 2022 $61.96M
Cash And Equivalents FY 2022 · Dec 31, 2021 $24.78M
Stockholders Equity FY 2022 · Dec 31, 2022 $113.04M
Stockholders Equity FY 2022 · Dec 31, 2021 $130.5M
Stockholders Equity FY 2022 · Dec 31, 2020 −$37.42M
Current Liabilities FY 2022 · Dec 31, 2022 $21.97M
Current Liabilities FY 2022 · Dec 31, 2021 $16.32M
Total Liabilities FY 2022 · Dec 31, 2022 $22.14M
Total Liabilities FY 2022 · Dec 31, 2021 $16.64M
Current Assets FY 2022 · Dec 31, 2022 $133.63M
Current Assets FY 2022 · Dec 31, 2021 $146.15M
Total Assets FY 2022 · Dec 31, 2022 $135.18M
Total Assets FY 2022 · Dec 31, 2021 $147.14M
Eps Diluted FY 2022 · Dec 31, 2022 −$2.71
Eps Diluted FY 2022 · Dec 31, 2021 −$2.65
Eps Basic FY 2022 · Dec 31, 2022 −$2.71
Eps Basic FY 2022 · Dec 31, 2021 −$2.65
Sga Expense FY 2022 · Dec 31, 2022 $15.74M
Sga Expense FY 2022 · Dec 31, 2021 $10.74M
Rd Expense FY 2022 · Dec 31, 2022 $61.4M
Rd Expense FY 2022 · Dec 31, 2021 $40.77M
Net Income FY 2022 · Dec 31, 2022 −$75.72M
Net Income FY 2022 · Dec 31, 2021 −$51.39M
Operating Income FY 2022 · Dec 31, 2022 −$77.14M
Operating Income FY 2022 · Dec 31, 2021 −$51.51M